Home
About
Overview
Sharing Data
ORCID
Help
History (75)
Glucose-6-Phosphate
Ferredoxin-Nitrite Reductase
MODY: a model for the study of the molecular genetics of NIDDM.
HLA-DR4 Antigen
Sequential hydroxyurea-cytarabine chemotherapy for refractory non-Hodgkin's lymphoma.
See All 75 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Sequential hydroxyurea-cytarabine chemotherapy for refractory non-Hodgkin's lymphoma.
Sequential hydroxyurea-cytarabine chemotherapy for refractory non-Hodgkin's lymphoma. J Clin Oncol. 1987 Mar; 5(3):419-25.
View in:
PubMed
subject areas
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols
Cytarabine
Drug Evaluation
Female
Humans
Hydroxyurea
Lymphoma, Non-Hodgkin
Male
Middle Aged
authors with profiles
Richard Schilsky